Story of Bioculture Group
Bioculture was founded by Mary-Ann and Owen Griffiths with a belief that medical research and biodiversity protection must advance together. Established in Mauritius, the company pioneered ethical, purpose-bred non-human primate (NHP) programs at a time when global standards were still emerging.
Over time, Bioculture evolved from a single breeding operation into a vertically integrated life sciences group, expanding into the United States and into preclinical and translational research.
2025
Launch of AnewCRO
2024
Investment in Franklin Biolabs
2023 onwards
Strategic growth focused on diversifying across the biomedical value chain with expansion in research services
2019 – 2020
An uptick in demand opens a rapid growth opportunity, with the workforce in Mauritius increasing fivefold
2009 – 2018
Downward trend for industry following Global Economic Crisis. Company focused on cost management and strengthening efficiency in operations
2012
Builds supply chain in the US, and sets up BCUS – site in Florida with CDC approved quarantine, and holding of animals for clients
2006
Bioculture launches its purpose-build animal data management software and obtains its AAALAC accreditation, which is to this date maintained.
1990 – 2009
Steady growth with a focus on building robust operations to deliver the gold standard in NHP models for Biomedical Research
1999
BCM becomes ISO 9001 certified
1992
Specific Pathogen Free (SPF) Status of Mauritian Cynomolgus Macaques is confirmed in a publication of Primates (vol. 33, 1992)
1985
Bioculture (Mauritius) Ltd founded, pioneering supply of MCMs for Biomedical research







